News
Schumer said she was having success on Mounjaro after previously being unable to "handle" Ozempic's side effects.
GLP-1 drugs are blockbuster medications for weight loss and Type 2 diabetes. Now doctors are trying them for lymphedema, ...
20h
MarketBeat on MSNHims' Weight Loss Expansion: Real Growth or Just Hype?CompanyOverview|NYSE:HIMS] One of the more hotly debated stocks in the market, Hims & Hers Health (NYSE: HIMS), recently made ...
In a New York Times column this week, the Pennsylvania Democrat shared his experience taking Mounjaro while advocating for ...
Food additive mixtures commonly found in diet drinks, soups, dairy desserts and sauces may slightly increase a person's risk ...
A new paper by the Institute for Clinical and Economic Review (ICER) looks at the cost-effectiveness versus affordability issue of obesity medications such as Wegovy and Zepbound.
Explore more
Sen. John Fetterman (D-Pa.) on Wednesday called on the Trump administration to back a Biden-era rule that would expand access ...
The infamous gossip blogger is backing the GLP-1 craze, applauding the celebrities who’ve been candid about their weight loss struggles and their experiences with drugs like Ozempic.
Semaglutide is an injectable medication that treats type 2 diabetes and obesity by regulating blood sugar levels. A ...
After massive gains in the past five years on the heels of the weight loss blockbuster Zepbound, Eli Lilly & Co (LLY) stock ...
The use of drugs like Ozempic, Wegovy and Zepbound in people with type 1 diabetes has risen sharply over the past decade, a ...
In November, Mr. Biden set out to change that with a new rule that would drastically expand access to this type of medication ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results